Belite Bio (BLTE) News Today → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free BLTE Stock Alerts $42.80 -0.40 (-0.93%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBelite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Resultsglobenewswire.com - May 8 at 8:00 AMBelite Bio (NASDAQ:BLTE) Shares Gap Down to $43.20marketbeat.com - May 6 at 5:55 PMBelite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebantglobenewswire.com - May 6 at 8:15 AMBelite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meetingglobenewswire.com - May 6 at 8:00 AMBLTE Belite Bio, Incseekingalpha.com - May 2 at 9:43 PMBelite Bio, Inc (NASDAQ:BLTE) Receives Consensus Recommendation of "Buy" from Analystsamericanbankingnews.com - May 2 at 2:22 AMBelite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meetingglobenewswire.com - May 1 at 4:15 PMShort Interest in Belite Bio, Inc (NASDAQ:BLTE) Declines By 13.0%marketbeat.com - April 28 at 8:15 PMBelite Bio secures $25 million in registered direct offeringinvesting.com - April 27 at 9:17 AMBelite Bio Announces $25 Million Registered Direct Offeringglobenewswire.com - April 25 at 7:15 PMBelite Bio (NASDAQ:BLTE) Trading 6.7% Higher marketbeat.com - April 18 at 4:55 PMBelite Bio Inc ADRmorningstar.com - April 13 at 7:32 PMBelite Bio, Inc (NASDAQ:BLTE) Sees Large Drop in Short Interestmarketbeat.com - April 12 at 2:30 PMBelite Bio (NASDAQ:BLTE) Shares Gap Down to $39.98marketbeat.com - April 9 at 12:11 PMBelite Bio (NASDAQ:BLTE) Stock Price Down 1.8%marketbeat.com - April 4 at 2:26 PMShort Interest in Belite Bio, Inc (NASDAQ:BLTE) Grows By 20.7%marketbeat.com - March 30 at 7:36 AMBelite Bio (NASDAQ:BLTE) Shares Down 4.8% marketbeat.com - March 27 at 3:24 PMBelite Bio, Inc: Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japanfinanznachrichten.de - March 23 at 1:07 AMBelite Retreats On Start Of Clinical Trialmsn.com - March 22 at 8:07 PMBuy Rating Affirmed on Belite Bio as Tinlarebant Shows Promising Clinical Advancements and Market Potentialmarkets.businessinsider.com - March 22 at 8:07 PMBelite Bio's (BLTE) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - March 22 at 11:44 AMBelite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japanglobenewswire.com - March 22 at 8:00 AMBuy Rating Justified for Belite Bio, Inc. ADR Amidst Promising DRAGON Trial Progress and Strong Financialsmarkets.businessinsider.com - March 21 at 9:46 PMBelite Bio, Inc Expected to Post Q1 2024 Earnings of ($0.40) Per Share (NASDAQ:BLTE)marketbeat.com - March 21 at 8:04 AMHere's Why We're Not Too Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn Situationfinance.yahoo.com - March 20 at 9:43 AMBelite Bio, Inc to Post FY2028 Earnings of $4.45 Per Share, Leerink Partnrs Forecasts (NASDAQ:BLTE)marketbeat.com - March 20 at 7:19 AMBelite Bio (NASDAQ:BLTE) Trading 5.9% Higher marketbeat.com - March 19 at 3:33 PMAnalysts’ Top Healthcare Picks: Belite Bio, Inc. ADR (BLTE), Catalyst Pharma (CPRX)markets.businessinsider.com - March 14 at 10:55 PMBelite Bio is Now Oversold (BLTE)nasdaq.com - March 14 at 5:54 PMBelite Bio, Inc (BLTE) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 14 at 5:54 PMAnalysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Belite Bio, Inc. ADR (BLTE) and Prothena (PRTA)markets.businessinsider.com - March 13 at 4:51 PMBelite Bio (NASDAQ:BLTE) Shares Gap Down to $39.04marketbeat.com - March 13 at 12:56 PMBelite Bio (NASDAQ:BLTE) Shares Down 4.6% marketbeat.com - March 12 at 1:44 PMBelite Bio Announces Availability of Annual Report on Form 20-F Through Company Websiteglobenewswire.com - March 11 at 10:28 PMBelite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - March 11 at 9:27 PMBelite Bio (BLTE) to Release Earnings on Tuesdaymarketbeat.com - March 7 at 1:08 PMBelite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Resultsglobenewswire.com - March 6 at 8:00 AMBelite Bio to Participate in the Leerink Partners Global Biopharma Conferenceglobenewswire.com - March 4 at 8:00 AMShort Interest in Belite Bio, Inc (NASDAQ:BLTE) Declines By 11.3%marketbeat.com - March 3 at 1:57 PMBelite Bio Stock (NASDAQ:BLTE) Insider Tradesbenzinga.com - February 21 at 9:21 PMShort Interest in Belite Bio, Inc (NASDAQ:BLTE) Decreases By 6.0%marketbeat.com - February 16 at 2:56 PMAtria Wealth Solutions Inc. Cuts Stock Position in Belite Bio, Inc (NASDAQ:BLTE)marketbeat.com - February 10 at 6:16 AMBelite Bio (NASDAQ:BLTE) Hits New 1-Year High at $47.00marketbeat.com - February 9 at 12:22 PMBelite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 7 at 8:28 AMFY2024 EPS Estimates for Belite Bio, Inc (NASDAQ:BLTE) Lowered by Leerink Partnrsmarketbeat.com - January 31 at 7:19 AMFY2028 Earnings Estimate for Belite Bio, Inc (NASDAQ:BLTE) Issued By Leerink Partnrsmarketbeat.com - January 30 at 7:16 AMBelite Bio (NASDAQ:BLTE) Sees Large Volume Increasemarketbeat.com - January 29 at 1:35 PMBelite Bio, Inc (NASDAQ:BLTE) Short Interest Updatemarketbeat.com - January 28 at 6:34 AMIs There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?finance.yahoo.com - January 9 at 10:33 AMShort Interest in Belite Bio, Inc (NASDAQ:BLTE) Expands By 19.5%marketbeat.com - December 31 at 12:17 PM Get Belite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter. Email Address 348 million Americans lives to END as we know it? (Ad)348 million American lives are about to change FOREVER.... Because thanks to one shocking A.I. development I'm revealing for the first time today... To see my free research, simply click here now. BLTE Media Mentions By Week BLTE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLTE News Sentiment▼0.300.36▲Average Medical News Sentiment BLTE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLTE Articles This Week▼61▲BLTE Articles Average Week Get Belite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MIRM News SYRE News COLL News IRWD News PCRX News GMTX News LGND News VRNA News MNKD News ABCL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLTE) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
